Zevra Therapeutics, Inc. logo

Zevra Therapeutics, Inc. (ZVRA)

Market Closed
12 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
12. 65
-0.32
-2.4672%
$
747.81M Market Cap
- P/E Ratio
- Div Yield
1.72M Volume
- Eps
$ 12.97
Previous Close
Add Transaction
Day Range
12.63 13.74
Year Range
7.16 14.27
Want to track ZVRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Zevra Therapeutics, Inc. (ZVRA) Statistics

Valuation metrics

Market Cap 747.81M
Enterprise value 653.36M
Trailing P/E (ttm) 5.95
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 6.12
Price/Book (mrq) 3.59
Enterprise Value/Revenue 5.34
Enterprise Value/EBITDA 4.65

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.63M
Average volume (90 days) 1.17M

Price summary

52-Week low 7.16
52-Week high 14.27
Beta -
50-Day moving average 10.6
200-Day moving average 9.33

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:16
Last split Date 28 Dec 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 1.02%
Operating margin -0.4%

Operational effectiveness

Return on assets 0.45%
Return on equity 0.81%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 2.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.13
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.64
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.89%
Book value per share (mrq) 3.52

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -